Fundraising Fox

Manuel Grossmann

Investor

Partner at Amino Collective

Berlin, Germany

Writes $5M – $10M checks · typically $7.5M

About

Manuel Grossmann is a founding partner at Amino Collective, an early-stage venture fund investing in health and biotech companies. He previously worked as an operator at Kry/Livi, a European digital health platform, and as an investor at Earlybird. Grossmann has backed over 30 companies across health and bio sectors, including Allcyte, Cradle, Enveda, Molecule, and Seqera.

Experience

  1. Amino CollectiveFounding Partnercurrent2020 — presentBerlin Metropolitan Area
  2. Tandem HealthSeed Investorcurrent2024 — presentStockholm, Stockholm County, Sweden
  3. Portal BiotechSeed Investorcurrent2022 — presentLondon Area, United Kingdom
  4. CradleSeed Investorcurrent2022 — presentAmsterdam Area
  5. Lindus HealthSeed Investorcurrent2021 — presentGreater London, England, United Kingdom
  6. SeqeraSeed Investorcurrent2021 — present
  7. Junction (formerly Vital)Seed Investorcurrent2021 — present
  8. AnimaSeed Investorcurrent2021 — present
  9. AllcyteSeed Investor2020 — 2021Vienna, Austria
  10. KRYDirector Business Development2018 — 2020Stockholm and Berlin
  11. Earlybird Venture CapitalAssociate2016 — 2018Berlin, Munich and New York City

Education

  1. Columbia Business SchoolMBA classes and research assistance
  2. Center for Digital Technology and Management (CDTM)Technology Management
  3. Technical University of MunichTechnology Management
  4. Zeppelin UniversityCorporate Management & Economics

Skills & more

Artificial Intelligence (AI)2Healthcare1Early-Stage Startups1Venture Capital9Techbio

Languages English · German · Spanish

From Manuel's professional profile.

Same school

Also attended Columbia Business School577

+ 571 more

Also attended Center for Digital Technology and Management (CDTM)27

+ 21 more

Also attended Technical University of Munich182

+ 176 more

Also attended Zeppelin University11

+ 5 more

Shared employers

Colleagues at Amino Collective